Skip to main content

Boris Mizhen - Happy to Donate to Yale-New Haven Hospital

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Throughout his career, Mizhen significantly supported national charities and eastern Tri-State nonprofits through generous financial contributions. Yale-New Haven, Connecticut's second-largest employer, is nationally recognized by US News & World Report as one of the country's leading hospitals, reflecting its excellence in healthcare and community service.

-- Boris Mizhen, well-known real estate developer, has donated to Connecticut’s Yale-New Haven Hospital, the premier institution for oncology, transplant surgery, and pediatrics in New England. Throughout his career, Mizhen remained an important financial contributor to both national charitable organizations and local non-profits in the eastern Tri-State area. Yale-New Haven is also the second-largest employer in Connecticut and is ranked among the top hospitals in the nation by US News & World Report.

“I’m very happy to give my financial assistance to the Yale-New Haven Hospital,” said Boris Mizhen. “For nearly two hundred years, the facility has been caring for the health of New England’s population in extraordinary ways. The hospital’s achievements include dozens of major medical breakthroughs, which have benefitted the entire world. I hope that my donation may contribute in at least a small way to their hugely positive work.”

Yale-New Haven Hospital was founded in 1826 as the General Hospital Society of Connecticut. Originally opened as a charitable institution caring for the poor, it soon expanded its scope to include the entire community. In particular, it helped many sailors from New Haven’s busy seaport, and during the Civil War, more than 25,000 Union soldiers were treated there. The Yale School of Medicine formalized its relationship with the hospital in 1913, developing a formal educational training program that served as the model to many teaching hospitals, to ultimately become the “Yale-New Haven Medical Center.”

Boris Mizhen is proud to sponsor such a historic and famous institution and is excited to witness what further developments it will achieve in its future. Yale-New Haven Hospital boasts an impressive list of accomplishments regarding its performance within the United States. It is the site for the first recorded use of medical X-Ray in 1896 and the first clinical distribution of penicillin in 1942. When chemotherapy was introduced onto its campus, it became the first place in the country to offer the treatment to its patients. It successfully identified and named Lyme disease in 1975 and produced the first insulin infusion pump for diabetics a year later. The nation’s initial fetal cardiovascular center was built there in 1985, and in 2002, it was recognized as the first US hospital to transplant nerve cells into the brain of a multiple sclerosis patient.

Boris Mizhen was a longtime resident of Guilford, Connecticut, which has instilled a particular affinity for the New England area and its many philanthropic organizations that have received his support. He now resides in New York City, where he leads a successful real estate development company. Through the Boris Mizhen Family Trust, he has expressed his support to a huge number of local and national charities, including the Jewish Foundation of Greater New Haven and the Chabad of Shoreline’s Jacob Fund. Mizhen dedicates considerable time to helping residents displaced by gentrification and towards making the sometimes inevitable neighborhood transition less destructive to the original character of a community.

Boris Mizhen - Property Developer and Philanthropist: http://borismizhennews.com

Boris Mizhen (@bmizhen) - Twitter: https://twitter.com/bmizhen

Boris Mizhen - Facebook: https://www.facebook.com/bmizhen

Contact Info:
Name: Boris Mizhen
Email: Send Email
Organization: BorisMizhenNews.com
Website: http://borismizhennews.com

Release ID: 89196274

Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.69
+5.68 (2.50%)
AAPL  283.78
+8.63 (3.14%)
AMD  521.58
-10.99 (-2.06%)
BAC  57.88
-0.31 (-0.53%)
GOOG  334.69
-7.50 (-2.19%)
META  550.25
+7.38 (1.36%)
MSFT  372.97
+20.14 (5.71%)
NVDA  192.53
-3.21 (-1.64%)
ORCL  148.53
-3.93 (-2.58%)
TSLA  379.71
+4.59 (1.22%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.